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Abstract: The membrane fusion events observed
during neutrophil degranulation are important as-
pects of the immunoregulatory system. In an at-
tempt to understand the regulation of granule-
plasma membrane fusion, we have begun
characterizing human neutrophil cytosol for fusion
activity, finding that 50% of the fusogenic activity
could be attributed to members of the annexin
family of proteins. The major non-annexin fusion
activity (25% of the total cytosolic activity) was
enriched by ion exchange chromatography after
depletion of annexins by Ca21-dependent phospho-
lipid affinity chromatography. The fusion activity
co-purified with a 10,14-kDa dimer identified as
leukocyte L1 (which was non-fusogenic), along with
an approximately 36-kDa protein. This protein was
identified as glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) by amino-terminal sequencing, and
the fusion activity was verified using commercially
available GAPDH. GAPDH may play an important
role in degranulation because it is as potent as annexin
I on a mass basis and may constitute up to 25% of the
total cytosolic fusion activity of the neutrophil. J.
Leukoc. Biol. 63: 331–336; 1998.
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INTRODUCTION
Neutrophil degranulation is an important aspect of the immune
system’s inflammatory response. Invagination of the plasma
membrane to engulf foreign particulates, followed by fusion of
these phagosomes with specific and azurophil granules contain-
ing bactericidal compounds and hydrolytic enzymes, are well-
known processes [1]. Although we have considerable knowl-
edge about neutrophil degranulation, the mechanism(s) and
regulation of the membrane-membrane interactions are not well
understood. It has been observed that the annexins, a class of
Ca21-dependent phospholipid binding proteins [2], can pro-
mote fusion of both phospholipid vesicles and neutrophil
specific granules [3, 4]. Therefore, they have been implicated
as potential mediators of the membrane fusion events observed
during degranulation.
There are several non-annexin proteins that have been shown
to mediate membrane fusion in systems analogous to neutro-
phils. The release of neurotransmitters at synaptic junction
sites is a membrane-membrane fusion event similar to degranu-
lation. This process in neurons is mediated by proteins such as
SNAP-25, VAMP, and NSF [5, 6]. These proteins have been
shown to effect neurotransmitter release on stimulation with
Ca21, which can reach the micromolar range locally [7].
Hypothesizing that neutrophil degranulation may be medi-
ated at least in part by one or more non-annexin fusogens, we
depleted human neutrophil cytosol of annexins, finding that
considerable fusion activity remained. Subsequent isolation,
partial purification, and analysis demonstrated that a signifi-
cant portion of the fusogenic activity was due to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). These results were
confirmed by Western blot, enzymatic assay, and fusion using
commercial GAPDH. We believe that native GAPDH may play
an important role in neutrophil degranulation.
MATERIALS AND METHODS
Reagents
Phosphatidylethanolamine (PE), phosphatidic acid (PA), N-[7-
nitrobenz-2-oxa-1,3-diazol-4-yl]-PE (NBD-PE), and rhoda-
mine-PE (Rh-PE) were purchased from Avanti Polar lipids
(Birmingham, AL). p-Xylene-bis-pyridinium bromide (DPX)
and 8-aminonaphthalene-1,3,6, trisulfonic acid disodium salt
(ANTS) were purchased from Molecular Probes (Eugene, OR).
Mouse anti-GAPDH was purchased from Biogenesis, Sandown,
NH. Protein-A Sepharose CL-4B, chicken muscle GAPDH
(95% pure protein, with ,0.01% 3-phosphoglyceric phospho-
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kinase and ,0.1% triosephosphate isomerase), ethylenediaminetet-
raacetate, ethyleneglycol-aminoethylether-N,N,N,N-tetraacetic acid
(EGTA), NaCl, KCl, N-2-hydroxyethylpiperazine-N8-2-ethanesul-
fonic acid (HEPES), dithiothreitol, MgCl2, molecular weight
standards, TEMED, DEAE Sephacel, and diisopropyl fluoro-
phosphate (DFP) were obtained from Sigma. All reagents for
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) were obtained from Bio-Rad (Richmond, CA). Leupep-
tin and aprotinin were obtained from Boehringer Mannheim.
Phenylmethylsulfonyl-fluoride was purchased from United States
Biochemical Co. (Cleveland, OH).
Cells
Neutrophils were isolated from the fresh venous blood of
healthy donors by use of the method of Boyum [8]. Briefly,
acid-citrate-dextrose anticoagulated venous blood was sepa-
rated on a Ficoll-Hypaque cushion, followed by dextran
sedimentation of red blood cells (RBC). Residual RBC were
removed by hypotonic lysis. The resulting neutrophils were
washed and suspended in buffer A (100 mM KCl, 50 mM
HEPES, 1 mM EGTA, pH 7.0) at 1 3 108/mL. After treatment
with DFP (2 mM), the neutrophils were disrupted by nitrogen
cavitation [9] and the nuclei removed by low-speed centrifuga-
tion in a Beckman J6 centrifuge (1000 g for 10 min at 4°C),
followed by removal of granules and plasma membrane by
ultracentrifugation (158,000 g for 30 min at 4°C).
HL-60 cells were also used for the final protein isolation and
purification step due to high cell yields and the presence of the
fusogenic activity in these cells. Cells were grown in RPMI
1640 supplemented with 10% fetal calf serum and 1%
penicillin-streptomycin. After washing of the undifferentiated
cells with phosphate-buffered saline (PBS), cell pellets were
treated with DFP, cavitated, and clarified as outlined for blood.
Fusogen purification
Annexins were removed from cytosol by exhaustive affinity
chromatography using a phospholipid column (3 PS:1 PE)
similar to that used for annexin purification in the presence of 1
mM Ca21, as previously described [10]. The pooled flow-
through was dialyzed into 10 mM sodium phosphate, pH 7.0,
and subjected to DEAE Sephacel anion-exchange chromatogra-
phy. The subsequent flow-through was dialyzed into 50 mM
MES, 0.1 mM EGTA, pH 5.5, and subjected to FPLC (MonoS
HR 10/10 cation exchange, Pharmacia, 17-1557-01). Elution
was at 1 mL/min with 0–1.0 M NaCl concentration gradient
executed over 50 min (see Fig. 2). Collected eluate fractions (1
mL) were dialyzed back into Buffer A for experimentation.
Fusion assay
Large unilamellar liposomes (LUV) composed of PA/PE (1:3)
were prepared by the reverse-phase evaporation method of
Duzgunes et al. [10, 11]. For lipid mixing assays, PA:PE (1:3)
LUV labeled with 1% NBD-PE and 1% Rh-PE were formed in
buffer A by reverse-phase evaporation. At these concentrations
of NBD-PE and Rh-PE, the distance between NBD and Rh was
sufficiently close that Rh quenched NBD fluorescence. Labeled
and unlabeled LUV (1:9, 180 µg total phospholipid) were
combined in a cuvette (final volume 1 mL) and fusion initiated
with the addition of increasing [Ca21]. Fusion between a
labeled and an unlabeled LUV resulted in an increase in the
distance between NBD and Rh and a decrease in quenching.
The resulting increase in NBD fluorescence was detected by a
SLM 8000 spectrofluorometer (excitation, 450 nm; emission,
530 nm).
Content mixing fusion was assayed with ANTS/DPX as
described by Wilschut et al. [12].
Miscellaneous procedures
Western blots were performed by the method of Gillespie [13].
Protein sequencing was carried out by the University of
Michigan Carbohydrate Facility using acid hydrolysis followed
by high-performance liquid chromatography. GAPDH enzyme
assays were performed according to Heinz and Freimuller [14].
RESULTS
The annexins have been implicated as potential fusogens
mediating the fusion between neutrophil granules and plasma
membrane fusion [4]. However, non-annexin fusogens have
been shown to be important in other cell systems and in fact
may work in conjunction with the annexins. To determine the
potential role of non-annexin fusogenic activity, we took
advantage of the characteristic affinity of annexins for phospho-
lipid vesicles [10]. Neutrophil cytosol was depleted of annexins
by Ca21-dependent affinity chromatography using a phosphati-
dylserine (PS)/PE liposome column. We found that, following
depletion of annexins by exhaustive affinity chromatography,
the column flow-through retained approximately half of total
cytosol fusion activity (Fig. 1). Annexin depletion was con-
firmed by Western blot analysis using an antibody to the
annexin consensus sequence (not shown).
The flow-through from the liposome affinity column was
subjected to anion-exchange chromatography on DEAE Sepha-
rose. Although 50% of total protein bound to the DEAE column,
virtually all of the fusion activity was found in the flow-through
(Fig. 1). The flow-through from the anion-exchange column was
bound to an FPLC cation exchange column and the remaining
proteins were eluted with a 0–1.0 M NaCl gradient. This eluate
was, according to the elution program, divided into five
fractions designated peak 1 (corresponding to 0.15–0.25 M
NaCl elution), peak 2 (0.25–0.35 M NaCl), peak 3 (0.35–0.50
M NaCl), peak 4 (0.50–1.00 M NaCl), and flow-through (Fig.
2). FPLC peak 2 contained most of the fusion activity present in
the initial affinity column flow-through, but only one-sixth of
the proteins. Because of this potent fusion activity, samples
were tested for trace amounts of annexin by Western blotting
and were found to be free of annexin (data not shown).
Figure 3 shows by SDS-PAGE that stepwise chromatogra-
phy removed most contaminating proteins from the fusogenic
fraction. Lanes 1, 2, 3, and 6 show the purification achieved in
cytosol, affinity column flow-through, anion exchange column
flow-through, and FPLC peak 2, respectively (other lanes show
proteins removed in anion column flow-through, FPLC flow-
through, and FPLC peaks 1, 3, and 4). It can be seen that the
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vast majority of protein in the fusogenic peak 2 (lane 6) was in a
low-molecular-weight range (about 10–15 kDa), whereas higher-
molecular-weight bands were faint. These prevalent bands were
believed to be the subunits of reduced leukocyte L1 protein, a
30-kDa multimer that is believed to constitute about 45% of
total neutrophil cytosolic protein [15]. Identity was confirmed
by reduced and non-reduced Western blots using antibodies to
L1 (not shown).
Further purification of the fusion activity was attempted by
use of size-selective membranes. Activity was retained by a
30-kDa cut-off filter, partially passed through a 50-kDa, and
completely passed through a 100-kDa filter (Amicon 4208,
Fig. 1. Fractionation scheme for concentrating non-annexin fusogen. Protein (mg), shown underlined, and fusion activity (arbitrary units), shown in italics, of
successive neutrophil cytosol preparatory fractions indicate that fusion activity was concentrated in FPLC peak 2 after 85% of total protein was removed. These
results were compiled from five separate experiments.
Fig. 2. Mono-S elution profile and fusion activity. Proteins were eluted from the Mono-S column using a NaCl gradient (0–1.0 M, at 1 mL/min). Samples were
pooled, designated peaks 1, 2, 3, and 4, and flow-through. These fractions were assayed for fusion activity using NBD-Rh fusion assay with PA/PE liposomes (results
are from a single representative experiment).
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4224, and 4211, respectively; not shown). Thus the estimated
molecular mass of the protein was between 30 and 100 kDa.
Because L1 was a primary component of our preparation, we
examined purified L1 isolated from human blood and authentic
lyophilized L1 (generously donated by Kenneth Miyasaki and
Nancy Hogg) [15, 16] for fusion activity. Both forms of authentic
protein lacked any appreciable activity in our fusion assay (data
not shown). We also attempted to immunodeplete the fusion
activity from our preparation by use of MAC 387 (a commercial
antibody against L1) and an antibody against L1 provided by
Nancy Hogg. Although significant amounts of L1 were removed,
the fusion activity was unaffected (not shown), indicating that
L1 was not responsible for membrane fusion in our system.
By comparing multiple preparations from neutrophils and
HL-60 cells, we found that fusogenic activity appeared to
correlate with the presence of a 36-kDa band that often
appeared in conjunction with L1. This band was purified from
HL-60 cells, excised, and subjected to acid hydrolysis and
sequencing. Peptide sequencing yielded a 100% homology
match to human liver GAPDH. Identity was confirmed by
Western blot using monoclonal antibody to GAPDH. As can be
seen in Figure 4, a 36-kDa band persisted in fusogenic
samples throughout the preparation. Lanes 1 and 2 contained
authentic human GAPDH (positive control) and bovine serum
albumin (negative control), respectively. Lane 3 contained
crude cytosol, lanes 4 and 5 contained affinity column flow-
through and eluate, lanes 6 and 7 contained anion-exchange
column flow-through and eluate, lane 8 contained FPLC
cation-exchange column flow-through, and lanes 9–12 con-
tained FPLC peaks 1, 2, 3, and 4, respectively. FPLC peak 2
(lane 10) contained the majority of the GAPDH in the FPLC
start material.
Assays of GAPDH enzymatic activity showed that the active
protein was enriched throughout the preparation as protein was
removed in column chromatography eluates. In particular, it
was found that GAPDH segregated almost completely to the
flow-throughs of the affinity- and anion-exchange columns.
Unfortunately, enzyme (but not fusion) activity was lost after
FPLC on the cation-exchange column. Thus, the enzyme assays
provided additional evidence that GAPDH was concentrated in
fractions with the highest fusion activity, at least until the final
preparatory step.
We confirmed that commercial GAPDH from chicken muscle
(but not from human erythrocytes, data not shown) promotes
Ca21- and dose-dependent fusion of PA/PE liposomes with
unlabeled complex liposomes (designed to mimic neutrophil
membrane composition; Fig. 5) [17]. We observed that 1 unit
(14 µg) of GAPDH was capable of inducing up to 45% of
Fig. 3. SDS-PAGE of the purification of non-annexin fusogen. Silver-stained
gel (14%) shows reduction of protein contaminants in relevant fractions. Lane
1, cytosol; lane 2, flow-through from phospholipid affinity column; lane 3,
flow-through from DEAE anion exchange column; lane 4, flow-through from
FPLC MonoS ion exchange column; lane 5, peak 1 (0.15–0.25 M NaCl) from
FPLC; lane 6, peak 2 (0.25–0.35 M NaCl) from FPLC; lane 7, peak 3
(0.35–0.50 M NaCl) from FPLC; lane 8, peak 4 (0.50–1.00 M NaCl) from FPLC.
Fig. 4. Western blot analysis of GAPDH. Fractions containing the non-
annexin fusogen were subjected to Western blot analysis using antibody against
GAPDH. It can be seen that GAPDH segregated predominantly to Mono S Peak
2. Lane 1, GAPDH positive control; lane 2, albumin-negative control; lane 3,
cytosol; lane 4, phospholipid affinity column flow-through; lane 5, phospholipid
affinity column eluate; lane 6, DEAE anion exchange column flow-through;
lane 7, DEAE anion exchange column eluate; lane 8, FPLC flow-through; lane
9, FPLC eluate peak 1 (0.15–0.25 M NaCl); lane 10, FPLC eluate peak 2
(0.25–0.35 M NaCl); lane 11, FPLC eluate peak 3 (0.35–0.50 M NaCl); lane 12,
FPLC eluate peak 4 (0.50–1.00 M NaCl).
Fig. 5. Ca21- and dose-dependent fusion of commercial GAPDH. Standard
fusion experiments were conducted using PA/PE (1:3) liposomes dually labeled
with NBD-PE and Rh-PE along with unlabeled complex liposomes (designed to
mimic neutrophil membrane composition) [17]. The liposomes were preincu-
bated for 1 min with the indicated concentration of commercial (chicken
muscle) GAPDH. Fusion was initiated with the addition of Ca21 to the
indicated level and was monitored for 90 s on an SLM spectrofluorometer
(excitation, 450 nm; emission, 530 nm). The data shown are from a single
representative experiment.
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maximal fusion at 500 µM free Ca21. Higher concentrations of
GAPDH or Ca21 produced more fusion signal.
We also wished to compare our native fusogen to both
annexin I and commercial GAPDH with respect to fusion
activity. As shown in Figure 6, 1 unit (14 µg) of commercial
GAPDH had very potent fusion activity. In addition, our
semi-purified samples containing native GAPDH (derived from
peak 2) were also highly fusogenic. As little as 4 µg (shown
above to contain approximately 90% L1) could induce fusion
equivalent to that of 4 µg human placenta annexin I (Fig. 6).
Thus we propose that native neutrophil GAPDH in our hands
may have up to 10 times the fusion activity of annexin I on a
mass basis.
DISCUSSION
We have outlined here the identification of a 36-kDa protein
partially purified from human neutrophils that can induce
fusion of unilamellar liposomes. This protein, identified by
sequencing as GAPDH, co-enriched with leukocyte L1 protein
(which was not a fusogen). We confirmed prior findings [18–21]
that GAPDH has potent fusion activity. We have also compared
commercial as well as human neutrophil GAPDH fusion
activity to annexin I, finding that GAPDH was more fusogenic
on a mass basis. Because our non-annexin fusogen comprised at
least 25% of the total cytosolic activity, we speculate that
GAPDH may be an important contributor to the degranulation
process.
This conclusion must be tempered with two considerations.
The first is that some contaminant in the commercial GAPDH
preparation might be responsible for the observed fusion. Sigma
reports that this preparation is 95% pure protein, with ,0.01%
3-phosphoglyceric phosphokinase and ,0.1% triosephosphate
isomerase. These contamination levels are not only very low but
to our knowledge neither of these enzymes has been reported to
possess fusion activity. Also, it is unlikely that the many
preparations of GAPDH that have been reported with fusion
activity [18–21] would all possess the same putative fusogenic
contaminant. The second consideration is that GAPDH, like
other glycolytic enzymes, is usually found both free in the
cytosol and bound to cytoskeleton [22–24]. We do not know how
much of the enzyme is free in neutrophils nor indeed whether
the bound enzyme has any fusogenic activity. Hence, the impact
of this distributed state of GAPDH on our findings is unclear.
The annexins are a class of Ca21-dependent phospholipid
binding proteins found in neutrophils and other secretory cells.
Annexin I has high affinity for both PS and PA [10], whereas
GAPDH does not bind to PS. In fact, this difference was
exploited in the isolation of GAPDH. Extremely small amounts
of PA are found in resting neutrophils. However, after activation
of the cells, membrane phosphatidylcholine is hydrolyzed to PA
by phospholipase D [25], resulting in transient elevated levels
of intracellular PA. It is hypothesized that granule-plasma
membrane apposition and fusion may in part be mediated by
the annexins through the newly generated PA [10, 26]. GAPDH,
which has no appreciable affinity for PS, appears to be a potent
endogenous fusogen that may also mediate granule-plasma
membrane fusion through PA.
Multiple potential interactions between GAPDH and mem-
brane phospholipids have been previously reported. Sidorowicz
et al. [27] found that interaction of rabbit muscle GAPDH with
negatively charged phospholipids decreases enzymatic activity,
and that nicotinamide adenine dinucleotide could protect
GAPDH from inactivation by membrane phosphatidylinositol.
Glaser et al. [18] proposed that a GAPDH isoform isolated from
rabbit brain cytosol could mediate Ca21-independent fusion of
complex liposomes constructed to resemble a biological mem-
brane (PC 27%, PS 6%, cholesterol 40%, and plasmenyletha-
nolamine 27%). This fusion was believed to be due to lipid
phase changes of plasmenylethanolamine mediated by GAPDH
that could not be achieved with phosphatidylethanolamine [19].
Although Ca21 was not required for catalysis of membrane
fusion in their system, it modulated the activity of the isoform
examined. In addition, isoforms that had dehydrogenase activ-
ity were distinguished from isoforms that catalyzed membrane
fusion activity. This could be related to our observation of an
apparent loss of enzymatic activity in the final FPLC fractions,
which retained fusion activity (data not shown).
Direct interactions between GAPDH and lipids were investi-
gated by Vinals et al. [20]. These investigators induced optimal
fusion of liposomes (9 PC:1 PA) with commercial GAPDH by
lowering pH to 5.0, demonstrating that increasing negative
charge on phospholipid vesicles also increased fusion potential
in the presence of GAPDH. However, Morero et al. [21]
demonstrated Ca21-independent fusion of 10% PA liposomes
mediated by commercial GAPDH, questioning whether GAPDH
fusogenicity was due solely to its affinity for acidic phospholip-
ids. We also detected low levels of Ca21-independent aggrega-
tion and fusion activities, but this accounted for only a small
Fig. 6. Comparative fusion activity between commercial GAPDH,
peak 2 and annexin I. Standard fusion experiments were performed
as described in the legend to Figure 4, except that a fixed [Ca21] of
1 mM was used and actual fluorimeter traces are shown. The data
compare the fusion potential of equivalent masses of peak 2
(partially purified endogenous GAPDH) and annexin I. A larger
mass of commercial GAPDH is shown for comparison. The data are
from a single representative experiment.
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fraction of that achievable with Ca21 (not shown). We have also
shown that GAPDH in our fusion system apparently has a
potential for Ca21-mediated fusion that is at least equivalent to
annexin I. Robbins et al. [28] recently discovered in late
endosomes that a single amino acid substitution in GAPDH
caused a marked difference in endocytosis of liquid phase
markers. Thus, it can be seen in an unrelated system that
GAPDH appears to serve in a membrane-membrane fusion
capacity.
Our data suggest a possible role for GAPDH in the neutrophil
degranulation process. Although fusogenic samples were not
purified to a single protein, our experimental data and related
research by other laboratories clearly implicate GAPDH as a
membrane fusion mediator. Further study may reveal this
protein to be an as yet unexplored factor of the degranulation
process.
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